Advertisement

Journal of Gastroenterology

, Volume 30, Issue 3, pp 356–366 | Cite as

Study of repeated arterial infusion chemotherapy with a subcutaneously implanted reservoir for advanced hepatocellular carcinoma

  • Akiharu Minoyama
  • Masaharu Yoshikawa
  • Masaaki Ebara
  • Hiromitsu Saisho
  • Nobuyuki Sugiura
  • Masao Ohto
Liver, Pancreas, and Biliary Tract

Abstract

We performed repeated arterial infusion chemotherapy (RAIC) in 114 advanced hepatocellular carcinoma (HCC) patients, using a subcutaneous reservoir implanted under ultrasonic guidance. In 60 patients, this was the initial therapy for the primary tumor and the other 54 patients being treated for recurrent tumor. One hundred and seventy-one patients with advanced HCC who had been treated by transcatheter arterial emblization (TAE) or single bolus arterial infusion chemotherapy before RAIC was available served as historical controls. In 97 patients, anticancer agents (4′-epidoxorubicin or acurarubicin) and Lipiodol emulsion were used, and in 17, anticancer agents alone were given. The response rates were 39.2% in the Lipiodol group and 17.6% in the non-Lipiodol group. The dose of Lipiodol and the degree of liver invasion were the most important factors influencing the response rate. The 1-, 2-, and 3-year survival rates were 55.0%, 30.9%, and 21.2%, respectively. The long-termsurvival was compared in relation to Child's classification and the presence or absence of portal vein tumor thrombosis (PVTT). In non-PVTT patients, the results of initial therapy and therapy for recurrence were similar, but recurrent Child's C patients showed a poorer prognosis. In PVTT patients, initial therapy had a better prognosis than treatment for recurrence, but initial Child's C patients had a poor long-termprognosis. During the observation period, no severe complications were encountered, but in Child's C patients, hepatic function sometimes deteriorated. Compared with the results in the 171 controls, RAIC was more useful for advanced HCC as initial therapy, and it was also beneficial for the treatment of recurrence after TAE.

Key words

hepatocellular carcinoma (HCC) arterial infusion chemotherapy reservoir portal vein tumor thrombosis Child's classification 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yamada R, Satou M, Kawabata T, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983;148:397–401.PubMedGoogle Scholar
  2. 2.
    Nakamura H, Mitani T, Murakami T, et al. Five-year survival after transcatheter chemoembolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 1994;33(Suppl):S89-S92.PubMedGoogle Scholar
  3. 3.
    Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918–928.PubMedGoogle Scholar
  4. 4.
    Patt YZ, Claghorn L, Charnsangavavej C, et al. Hepatocellular carcinoma. A retrospective, analysis of treatments to manage disease confined to the liver. Cancer 1988;61:1884–1888.PubMedGoogle Scholar
  5. 5.
    Leung WT, Shiu WCT, Leung N. Treatment of inoperable hepatocellular carcinoma by intraarterial Lipiodol and 4′epidoxorubicin. Cancer Chemother Pharmacol 1992;29:401–404.CrossRefPubMedGoogle Scholar
  6. 6.
    Yoshikawa M, Ebara M, Nakano, T, et al. Percutaneous transaxillary insertion for hepatic artery infusion chemotherapy. AJR 1992;158:885–886.PubMedGoogle Scholar
  7. 7.
    World Health Organization. WHO handbook for reporting results of cancer treatment. WHO offset publication No. 48. Geneva: WHO, 1979.Google Scholar
  8. 8.
    Yamamoto M, Sugahara, K. Overview of the general rules for the clinical and pathological study of primary liver in Japan. In: Tanikawa T, Kojiro K (eds) Primary liver cancer in Japan. Tokyo Berlin Heidelberg New York: Springer, 1992;385–392.Google Scholar
  9. 9.
    Chen HGS, Gross JF. Intra-arterial infusion of anticancer drugs: Theoretic aspects of drug delivery and review of response. Cancer Treat Rep 1980;64:31–34.PubMedGoogle Scholar
  10. 10.
    Yoshikawa M, Saisho H, Ebara M, et al. A randomized trial of intrahepatic arterial infusion of 4′-epidoxorubicin with Lipiodol versus 4′-epidoxorubicin alone in the treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol 1994;33(Suppl): S149-S152.PubMedGoogle Scholar
  11. 11.
    Ogawa R, Nakamura K, Takada K, et al. Intermittent intraarterial infusion chemotherapy using a subcutaneously implanted reservoir in patients with hepatoma. Gastroenterol Jpn 1994; 91(2):171–179.Google Scholar
  12. 12.
    Nakamura K, Takashima S, Takada K, et al. Clinical evaluation of intermittent arterial infusion chemotherapy with an implanted reservoir for hepatocellular carcinoma. Cancer Chemother Pharmacol 1992;31:93–98.Google Scholar
  13. 13.
    Yasui M, Nonami T, Kurokawa T, et al. Effects of hepatic arterial infusion chemotherapy on unresectable or recurrent hepatocellular carcinoma. Cancer Chemother Pharmacol 1994; 33(Suppl):S139-S141.PubMedGoogle Scholar
  14. 14.
    Iwamiya T, Sawada S, Ohta Y. Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system. Cancer Chemother Pharmacol 1994;33(Suppl):S134-S138.PubMedGoogle Scholar
  15. 15.
    Yumoto Y, Jinno K, Tokuyama K, et al. Hepatocellular carcinoma detected by iodized oil. Radiology 1985;154:19–24.PubMedGoogle Scholar
  16. 16.
    Miller D, O'Leavy TJ, Griton M. Distribution of iodized oil within the liver after hepatic arterial injection. Radiology 1987; 162:849–851.PubMedGoogle Scholar
  17. 17.
    Fujimoto J, Okamoto E, Yamanaka N, et al. Flow cytometric DNA analysis of hepatocellular carcinoma. Cancer 1991;67: 939–944.PubMedGoogle Scholar
  18. 18.
    Ebara M, Ohto M, Shinagawa T, et al. Natural history of minute hepatocellular carcinoma smaller than 3 cm complicating cirrhosis. Gastroenterology 1986;90:289–298.PubMedGoogle Scholar
  19. 19.
    Chung VC, Wallace S. Hepatic artery embolization in the treatment of hepatic neoplasm. Radiology 1981;140:51–58.Google Scholar
  20. 20.
    Takayasu K, Moriyama N, Muramatsu Y, et al. Hepatic arterial embolization for hepatocellular carcinoma. Comparison of CT scans and resected specimens. Radiology 1984;150:661–665.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • Akiharu Minoyama
    • 1
  • Masaharu Yoshikawa
    • 1
  • Masaaki Ebara
    • 1
  • Hiromitsu Saisho
    • 1
  • Nobuyuki Sugiura
    • 1
  • Masao Ohto
    • 1
  1. 1.First Department of Internal MedicineChiba University School of MedicineChibaJapan

Personalised recommendations